Canine Total Knee Replacement Market Poised for 7.1% CAGR Growth

Trishita Deb
Trishita Deb

Updated · Aug 20, 2025

SHARE:

Market.us Media, we strive to bring you the most accurate and up-to-date information by utilizing a variety of resources, including paid and free sources, primary research, and phone interviews. Learn more.
close
Advertiser Disclosure

At Market.us Media, we strive to bring you the most accurate and up-to-date information by utilizing a variety of resources, including paid and free sources, primary research, and phone interviews. Our data is available to the public free of charge, and we encourage you to use it to inform your personal or business decisions. If you choose to republish our data on your own website, we simply ask that you provide a proper citation or link back to the respective page on Market.us Media. We appreciate your support and look forward to continuing to provide valuable insights for our audience.

Overview

New York, NY – August 20, 2025: The Global Canine Total Knee Replacement (TKR) Market is projected to grow from US$ 422.9 K in 2024 to US$ 832.5 K by 2034, reflecting a CAGR of 7.1% during 2025–2034. Growth is driven by the increasing prevalence of osteoarthritis in dogs and rising demand for advanced veterinary care. Large and active breeds, where conventional surgeries such as TPLO or TTA fail, are key beneficiaries. With improved implant materials, advanced surgical planning, and rising owner willingness to invest, this niche market is expanding steadily.

Specialized veterinary hospitals and clinics are strengthening their orthopedic offerings. Companies including BioMedtrix, Fitzpatrick Referrals, and KYON AG are leading the field with innovative TKR systems. Digital surgical planning, cementless fixation, and breed-specific implants are enhancing outcomes. BioMedtrix’s Canine Total Knee™ system remains a widely adopted solution, offering both cemented and press-fit fixation. The procedure involves advanced imaging followed by femoral and tibial replacement with cobalt-chromium prostheses and polyethylene inserts, ensuring secure fixation and improved post-operative mobility. Rehabilitation is vital for optimal recovery.

The demand for canine TKR is supported by rising companion animal longevity and the increasing incidence of degenerative joint diseases. Osteoarthritis, the most common orthopedic condition in dogs, affects about 2.5% clinically and up to 20% post-mortem according to the American College of Veterinary Surgeons. While TPLO and TTA remain initial treatments, severe or failed cases necessitate TKR. The procedure helps restore mobility, reduce chronic pain, and improve life quality in aging or highly active dogs, making it a critical solution in veterinary orthopedics.

Government funding and global animal health initiatives further enhance access to advanced treatments. In the U.S., USDA APHIS provides funding to improve veterinary care, while the World Organisation for Animal Health (WOAH) sets standards through programs such as the PVS Pathway. Increasing humanization of pets also boosts demand, with owners viewing pets as family members. Asia is witnessing significant growth due to rising pet adoption, with nearly 60% of households owning pets and 32% considering dogs and cats as best companions, driving demand for specialized surgeries.

Canine Total Knee Replacement Market Size

Key Takeaways

  • In 2024, the canine total knee replacement market generated revenue of US$ 422.9K and is projected to hit US$ 832.5K by 2034.
  • The market displayed a CAGR of 7.1%, reflecting steady demand growth for canine total knee replacement procedures over the forecast period.
  • Among product types, implant systems dominated with a significant 73.6% share in 2024, highlighting their strong adoption across veterinary practices.
  • Metals and metal alloys led the material type segment, accounting for 66.3% of the canine total knee replacement market share in 2024.
  • Veterinary hospitals and clinics remained the primary end-users, generating 86.6% of total revenues in 2024 due to advanced infrastructure and skilled professionals.
  • North America emerged as the leading region, with the United States capturing a remarkable 92.0% share of the global canine TKR market in 2024.

Regional Analysis

North America is dominating the canine total knee replacement (TKR) market, led by the United States, which holds 92.0% of the share in 2024. The growth is attributed to advanced veterinary infrastructure, high consumer spending on pet health, and strong adoption of pet insurance. Early availability of orthopedic implant systems has further supported market penetration. These factors, combined with the rising humanization of pets, are driving demand for advanced surgical procedures, positioning the U.S. as the clear leader in this segment.

The U.S. pet industry demonstrates consistent growth, reflecting a strong foundation for the canine TKR market. According to the American Pet Products Association (APPA), pet industry expenditure reached $152 billion in 2024. Out of this, $39.8 billion was allocated to veterinary care and products, projected to rise to $41.4 billion in 2025. This steady increase indicates robust demand for advanced veterinary procedures. As a result, total knee replacement is expected to witness higher adoption among pet owners seeking improved orthopedic care.

Pet insurance adoption in the United States also plays a vital role in supporting TKR growth. The North American Pet Health Insurance Association (NAPHIA) reported nearly 6.25 million insured pets in 2024. Orthopedic surgeries, including total knee replacement, rank among the top reimbursed treatments. Insurance coverage reduces the financial burden on pet owners, making advanced procedures more accessible. This trend ensures the sustainability of market expansion while reinforcing the U.S. position as the most advanced region in terms of veterinary orthopedic services.

The Asia Pacific region is forecasted to record significant growth during the study period. Australia, in particular, represents a promising market with 69% of households owning pets, and 48% owning at least one dog. Pet humanization trends are fueling demand for advanced surgical interventions, including TKR. According to Animal Medicines Australia (AMA), pet owners spent AUD 3 billion (~US$ 2 billion) on veterinary services in 2023. The rise in pet insurance enrollment in metropolitan regions has further improved access to expensive orthopedic procedures, supporting strong market potential.

Segmentation Analysis

The implant systems segment accounted for 73.6% share in 2024. These systems are designed to replace damaged canine stifle joints, improving mobility and reducing pain in dogs with severe osteoarthritis or trauma. Components such as femoral, tibial, and patellar implants are manufactured using titanium, cobalt-chromium alloys, and UHMWPE. Innovation is driven by cementless fixation and biologically integrative designs. Growing adoption by veterinary specialists and use of human orthopedic designs in veterinary care further contribute to market growth, with products from BioMedtrix and KYON AG leading advancements.

The metals and metal alloys segment dominated material type usage in 2024 with a 66.3% share. These materials provide durability, mechanical strength, and biocompatibility, making them vital for canine TKR systems. Titanium and titanium alloys, particularly Ti-6Al-4V, are widely adopted due to corrosion resistance and osseointegration properties. Cementless implant techniques and porous coatings are fueling demand for advanced designs. Clinical evidence demonstrates long-term stability, with cementless titanium implants showing over six years of functional success in large breeds, positioning metals as the most reliable material category.

Veterinary hospitals and clinics represented 86.6% of the end-user market share in 2024. These facilities perform the majority of TKR surgeries and provide essential post-operative care. Equipped with advanced imaging and anesthesia systems, they employ board-certified orthopedic surgeons skilled in complex procedures. Rehabilitation offerings, including hydrotherapy, laser therapy, and physiotherapy, ensure effective recovery. More than 75% of all orthopedic surgeries, including total knee replacements, are conducted in referral hospitals and specialty clinics, particularly across North America and Europe, where adoption of advanced veterinary orthopedic solutions remains highest.

Key Players Analysis

The global canine total knee replacement (TKR) market in 2024 is influenced by a blend of implant innovators, veterinary orthopedic specialists, and suppliers of surgical devices. BioMedtrix, LLC, based in the U.S., has played a pioneering role by introducing one of the earliest complete canine TKR systems. Fitzpatrick Referrals, a leading UK-based center, is recognized for its advanced custom knee replacement procedures. Narang Medical, headquartered in India, is strengthening its position with competitively priced orthopedic instruments and wide global reach, driving accessibility and adoption.

Several specialized players are also contributing to the competitive structure of this market. Innoplant Medizintechnik GmbH, a Germany-based company, provides high-quality implants and advanced veterinary solutions tailored for joint replacement. KYON AG, based in Switzerland, has built a reputation through innovation in veterinary orthopedic implants and surgical techniques. OrthoMed UK Ltd further strengthens the European presence, offering a diverse portfolio of orthopedic products designed for animal healthcare, including specialized implants and instruments for joint reconstruction.

The increasing demand for canine TKR procedures is ensuring a growing role for these companies across regions. BioMedtrix continues to expand its dominance with extensive product development. Fitzpatrick Referrals demonstrates leadership by advancing customized treatment models. Narang Medical enhances access to cost-effective solutions through its global supply chain. Alongside them, KYON AG, Innoplant Medizintechnik GmbH, and OrthoMed UK Ltd provide specialized offerings, strengthening competition and innovation. Together, these companies are shaping the trajectory of the canine TKR market in 2024 with advanced solutions and regional expertise.

Emerging Trends

Growing Clinical Acceptance at Specialist Centers

Total Knee Replacement (TKR) is gaining wider clinical acceptance in veterinary medicine. Referral hospitals and orthopaedic centres are performing more TKR surgeries as surgeons develop greater expertise. Improved implant options also contribute to this trend. Specialist centres now promote TKR as a treatment for severe stifle (knee) disease when other options fail, such as cruciate repair or medical management. This shift highlights growing confidence among veterinary surgeons. The increase in case numbers at referral hospitals indicates that TKR is moving beyond experimental status. It is now seen as a viable solution for advanced joint disease in dogs.

Move Toward Cementless and Hybrid Implants

Traditional canine knee replacements used cemented implants. However, newer implant designs are moving toward cementless and hybrid systems. Cementless implants use porous or coated surfaces that allow natural bone to grow onto the implant. This biological fixation improves stability over time and reduces some risks associated with cement. Clinical studies and case reports show successful medium- and long-term outcomes with these newer systems. The availability of multiple implant designs widens surgical choices and supports better patient outcomes. Surgeons can now choose between cemented, cementless, or hybrid systems depending on patient factors. This trend reflects steady technological progress.

Better Implant Sizing and Custom Options

Implant design improvements are making TKR more adaptable for dogs of different breeds and sizes. Modern systems now offer a wide range of femoral and tibial component sizes. Modular inserts are available to fine-tune joint alignment. In some cases, custom or patient-specific implants are developed to match unique bone shapes. This ensures better anatomical fit and improved post-surgery function. Specialist clinics use implant customisation as a key selling point to pet owners. With improved alignment and tailored sizing, long-term outcomes are enhanced. These advances are helping TKR become a more predictable and successful option in veterinary orthopaedics.

Stronger Focus on Rehabilitation and Outcomes

Rehabilitation is now seen as an essential part of successful TKR surgery. Clinics emphasise structured recovery programmes that include muscle strengthening, gait training, and controlled activity. Research shows that rehabilitation reduces recovery time and improves mobility outcomes. Objective gait analysis and kinematic studies are increasingly used to measure results. These studies provide evidence of functional improvement and help refine protocols. The shift from subjective to measurable outcomes is improving the credibility of TKR as a treatment option. Rehabilitation is not just supportive care; it is a central factor that drives the long-term success of the procedure.

Improved Short-Term Recovery Timelines

Clinical studies report faster recovery timelines following TKR in dogs. With structured rehabilitation, many patients regain normal activity within 8–12 weeks. Earlier reports suggested longer recovery periods, but new protocols are changing expectations. Owners are more willing to consider TKR when informed that their dog may return to activity within three months. This improvement in recovery time is being used as a justification for the procedure. Faster recovery also enhances the perceived value of surgery compared to conservative management. Veterinary centres highlight these success stories to build confidence among owners. This trend makes TKR more acceptable and accessible.

Case Volumes Low but Rising

Despite positive developments, TKR remains a specialised procedure. It is not yet common in general veterinary practices. Most cases are concentrated in referral hospitals and advanced orthopaedic centres. Volumes remain much lower compared to cruciate ligament repairs, which are routine procedures. However, the number of cases is rising each year as awareness and clinical experience grow. Continued improvements in implants and rehabilitation protocols will likely support wider adoption. While still considered niche, TKR is gradually expanding beyond early adopters. This steady rise indicates that the procedure is moving toward a more recognised role in veterinary orthopaedics.

Research Gaps and Data Opportunities

A recurring theme in veterinary TKR literature is the lack of large-scale outcome data. Most studies remain small or single-centre reports. Authors frequently call for multi-centre registries to track complications, revision rates, and implant survival. Establishing such databases would provide valuable long-term insights. It would also allow standardisation of outcome measures across different clinics. This gap creates an opportunity for collaborative research networks and industry partnerships. Better data will help refine implant design, improve surgical techniques, and support clinical decision-making. Addressing this research gap is essential for advancing TKR from a specialised option to a mainstream solution.

Use Cases

Salvage for Irreparable Joint Damage

TKR is used when the knee joint is too damaged for partial repair. Severe osteoarthritis, bone loss, or failed surgeries are common reasons. In such cases, replacing the entire joint is the only solution. Studies report strong recovery outcomes when rehabilitation is followed. Many dogs can return to normal activity within 12 weeks. A clinical study on cemented implants found that most dogs achieved full activity at this stage. This shows that TKR provides predictable recovery and restores function in dogs that cannot benefit from partial joint repair.

Young Dogs with End-Stage Joint Disease

Some dogs develop advanced knee disease early in life. Working dogs or athletic pets often need to remain highly active. For these cases, TKR offers an option to restore near-normal movement. Clinical case reports show rapid recovery and a return to high performance after surgery. Owners of young, active dogs report good satisfaction when this option is chosen. Long-term studies also support implant survival. For example, cementless implants have shown survival of more than six years in follow-ups. This makes TKR a valuable choice for young dogs with severe knee disease.

Complex Revision After Failed Surgeries

TKR is also used when earlier surgical procedures fail. Failed implants, progressive bone loss, or worsening joint disease may require a complete replacement. In these complex cases, TKR acts as a revision strategy. Reports from veterinary literature highlight the effectiveness of this approach. Studies covering both dogs and cats describe the use of TKR for salvage and revision. However, they also emphasize the need to track complication and revision rates more closely. Even in these difficult cases, TKR offers a solution when other methods are no longer viable.

Patients with Severe Pain and Quality of Life Needs

Chronic knee pain can severely affect a dog’s quality of life. When medical treatments fail to control pain, TKR is considered. The replacement removes the painful joint and restores comfortable movement. Owners report large improvements in their pets’ activity and comfort after surgery. Specialist centers also publish outcomes showing significant reductions in pain. Objective gait studies confirm functional improvement. For many families, the main goal is to relieve pain and give the pet a normal life. TKR offers this opportunity and is often chosen when quality of life is the priority.

Clinical Research and Implant Testing

Veterinary schools and implant developers use TKR to study joint biomechanics and implant performance. Both cemented and cementless fixation methods are tested in clinical cases. Rehabilitation approaches are also evaluated through these procedures. Published studies provide early outcome data. For example, a 24-dog cemented implant study reported excellent joint stability in around 67% of cases. Although these studies are small, they form the foundation for further development. Clinical research continues to refine implant design, improve recovery methods, and support long-term success in canine TKR.

Education and Growth of Specialty Services

TKR is also used as an advanced clinical service in veterinary hospitals. Teaching institutions and referral clinics adopt TKR to expand their offerings. Universities report performing their “first TKR,” while specialty clinics advertise the service to attract referrals. These cases serve both educational and clinical purposes. Young surgeons gain training in advanced procedures, while patients receive cutting-edge treatment. The growing adoption of TKR reflects its rising role in veterinary orthopedics. As more clinics introduce it, access to this treatment option will continue to expand for dog owners and patients.

Conclusion

The canine total knee replacement market is steadily growing as a specialized solution in veterinary orthopedics. Rising cases of joint disease, longer pet lifespans, and higher owner willingness to invest in advanced care are supporting this trend. Veterinary hospitals and referral centers are leading adoption with skilled surgeons, modern imaging, and structured rehabilitation programs. Advances such as cementless implants, breed-specific sizing, and custom options are improving surgical outcomes. While the procedure remains niche, clinical acceptance is expanding as more success stories and data emerge. With increasing pet insurance coverage and growing humanization of pets, canine total knee replacement is positioned to become a vital option in advanced veterinary care.

View More

Total Knee Replacement Market || Knee Hyaluronic Acid Injections Market || Knee Replacement Market || Knee Osteoarthritis Treatment Market || Bone Growth Stimulator Market || Bone Graft Substitutes Market || Bone Replacement Market || Bone Wax Market || Bone Anchored Hearing Aids Baha Implants Market || Bone Graft Harvester Market || Demineralized Bone Matrix Market || Orthopedic Bone Cement Market

Discuss your needs with our analyst

Please share your requirements with more details so our analyst can check if they can solve your problem(s)

SHARE:
Trishita Deb

Trishita Deb

Trishita has more than 8+ years of experience in market research and consulting industry. She has worked in various domains including healthcare, consumer goods, and materials. Her expertise lies majorly in healthcare and has worked on more than 400 healthcare reports throughout her career.

Latest from the featured industries
Request a Sample Report
We'll get back to you as quickly as possible